MiraDx Reaps $1M Investment From Connecticut Innovations | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MircoRNA test developer MiraDx has received a $1 million investment through the Eli Whitney Fund of Connecticut Innovations, a technology-focused economic development group, CI said today.

For the firm, which is based in New Haven, Conn., the $1 million investment is part of its Series A round of financing that will add up to a total of $4 million, CI said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.